Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Parkinson Drug Recalled
03/20/2020
The presence of a foreign tablet in a bottle has prompted the FDA to recall a prescription drug used to treat symptoms of Parkinson disease.
The presence of a foreign tablet in a bottle has prompted the FDA to recall a prescription drug used to treat symptoms of Parkinson disease.
The presence of a foreign tablet...
03/20/2020
Pharmacy Learning Network

Advertisement

News
Pain Reliever Recalled
03/20/2020
A Class II recall is active for an analgesic medication used to treat mild to moderate pain and to reduce fever.
A Class II recall is active for an analgesic medication used to treat mild to moderate pain and to reduce fever.
A Class II recall is active for...
03/20/2020
Pharmacy Learning Network
News
Antacid Solution, Tablets Recalled
03/20/2020
A prescription drug used to treat ulcers, gastroesophageal reflux disease, and other conditions that cause excess stomach acid is being recalled.
A prescription drug used to treat ulcers, gastroesophageal reflux disease, and other conditions that cause excess stomach acid is being recalled.
A prescription drug used to...
03/20/2020
Pharmacy Learning Network
News
Mask Shortage Straps Pharmacists Who Need Them to Keep Medicines Pure
03/20/2020
Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks.
Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks.
Fifteen percent of hospital...
03/20/2020
Pharmacy Learning Network

Advertisement

News
Corticosteroid Spray Recalled
03/13/2020
A Class II recall is ongoing for a prescription corticosteroid used to treat plaque psoriasis in adults.
A Class II recall is ongoing for a prescription corticosteroid used to treat plaque psoriasis in adults.
A Class II recall is ongoing for...
03/13/2020
Pharmacy Learning Network
News
Ulcerative Colitis Drug Recalled
03/13/2020
A prescription nonsteroidal anti-inflammatory drug used to treat ulcerative colitis and to prevent ulcerative colitis flare-ups is being recalled.
A prescription nonsteroidal anti-inflammatory drug used to treat ulcerative colitis and to prevent ulcerative colitis flare-ups is being recalled.
A prescription nonsteroidal...
03/13/2020
Pharmacy Learning Network
News
Biopharmaceutical Medication Recalled
03/12/2020
Sterility concerns have prompted Pfizer Inc. to issue a voluntary recall for nearly 25,000 vials of Elelyso (taliglucerase alfa) for injection.
Sterility concerns have prompted Pfizer Inc. to issue a voluntary recall for nearly 25,000 vials of Elelyso (taliglucerase alfa) for injection.
Sterility concerns have prompted...
03/12/2020
Pharmacy Learning Network

Advertisement

News
Eye Ointment Recalled
03/04/2020
The FDA is recalling an over-the-counter medication used to reduce cornea swelling in patients with certain eye conditions.
The FDA is recalling an over-the-counter medication used to reduce cornea swelling in patients with certain eye conditions.
The FDA is recalling an...
03/04/2020
Pharmacy Learning Network
News
Pain Meds Recalled
03/04/2020
A nationwide recall is ongoing for a narcotic pain medication used to treat moderate to severe pain.
A nationwide recall is ongoing for a narcotic pain medication used to treat moderate to severe pain.
A nationwide recall is ongoing...
03/04/2020
Pharmacy Learning Network
News
Class I Recall Issued for Anticonvulsant
03/04/2020
A prescription anticonvulsant used to prevent and control seizures is being recalled.
A prescription anticonvulsant used to prevent and control seizures is being recalled.
A prescription anticonvulsant...
03/04/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use